Cushing Syndrome

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

NAC- NAFLD And Cushing

Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

Adrenal Tumors - Pathogenesis and Therapy

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome

Institutional Registry of Rare Diseases

Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Establishment and Clinical Application of Reference Intervals of Salivary Cortisol

Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)

A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome

Open-label Treatment in Cushing's Syndrome

Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT

Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders

Quality of Life, Fatigue and Cognitive, Affective and Emotional Dysfunction in Patients With Cushing's Syndrome

Cushing's Syndrome Before and After Treatment (CORRECT)

Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models